SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice

Jin Hong Shin, Brian Bostick, Yongping Yue, Roger Hajjar, Dongsheng Duan

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Background: Cardiomyocyte calcium overloading has been implicated in the pathogenesis of Duchenne muscular dystrophy (DMD) heart disease. The cardiac isoform of sarcoplasmic reticulum calcium ATPase (SERCA2a) plays a major role in removing cytosolic calcium during heart muscle relaxation. Here, we tested the hypothesis that SERCA2a over-expression may mitigate electrocardiography (ECG) abnormalities in old female mdx mice, a murine model of DMD cardiomyopathy.Methods: 1 × 1012 viral genome particles/mouse of adeno-associated virus serotype-9 (AAV-9) SERCA2a vector was delivered to 12-m-old female mdx mice (N = 5) via a single bolus tail vein injection. AAV transduction and the ECG profile were examined eight months later.Results: The vector genome was detected in the hearts of all AAV-injected mdx mice. Immunofluorescence staining and western blot confirmed SERCA2a over-expression in the mdx heart. Untreated mdx mice showed characteristic tachycardia, PR interval reduction and QT interval prolongation. AAV-9 SERCA2a treatment corrected these ECG abnormalities.Conclusions: Our results suggest that AAV SERCA2a therapy may hold great promise in treating dystrophin-deficient heart disease.

Original languageEnglish
Article number132
JournalJournal of Translational Medicine
Volume9
Issue number1
DOIs
StatePublished - 11 Feb 2011

Fingerprint

Dive into the research topics of 'SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice'. Together they form a unique fingerprint.

Cite this